ArticleBioMed research international2026
Antibacterial Activity of Corryocactus brevistylus (Sanky) Methanolic Extract Against Staphylococcus aureus and Enterococcus faecalis.
Article in BioMed research international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Antibacterial Activity of Corryocactus brevistylus (Sanky) Methanolic Extract Against Staphylococcus aureus and Enterococcus faecalis.BioMed research international · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundStaphylococcus aureus and Enterococcus faecalis are bacteria for which new antibiotics are urgently needed. Corryocactus brevistylus is a Peruvian cactus with an antibacterial effect that has not yet been studied.
objectiveTo determine the antibacterial effect of C. brevistylus methanol extract against S. aureus (ATCC 6538) and E. faecalis (ATCC 29212).
methodsSanky fruits were extracted with methanol (1:2, w/v). Agar well diffusion tests were used by preparing wells with the experimental solutions cultivated in aerobic conditions for 24 h at 37°C. Six independent tests were prepared for each type of bacteria, using penicillin-streptomycin and chlorhexidine as positive controls. The MIC was determined using the microdilution method as described by the CLSI.
resultsThe antibacterial effect of the methanol extract was dose-dependent, with inhibition zones of 23.33 ± 0.72 and 24.34 ± 0.55 mm against S. aureus and E. faecalis, respectively, at the highest concentration. Meanwhile, penicillin-streptomycin (10 U) and chlorhexidine produced inhibition zones comparable to the extract at the highest concentration. The MIC achieved by the extract was 15.6 mg/mL for both S. aureus and E. faecalis, while the MBC for S. aureus was 62.5 mg/mL and for E. faecalis 31.3 mg/mL.
conclusionsWeak antibacterial potency was observed in the methanolic extract of C. brevistylus against the strains of S. aureus and E. faecalis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.